Synergy for Klebsiella meningitis

The phrase "synergy for Klebsiella meningitis" does not represent a discrete disease entity, formal diagnostic classification, or standalone regulatory indication Instead, it describes a therapeutic strategy involving combination antimicrobial therapy aimed at achieving synergistic bactericidal activity against *Klebsiella pneumoniae* central nervous system infections, which are frequently multidrug-resistant or healthcare-associated *Klebsiella* meningitis is a severe, life-threatening infectio...

The phrase "synergy for Klebsiella meningitis" does not represent a discrete disease entity, formal diagnostic classification, or standalone regulatory indication Instead, it describes a therapeutic strategy involving combination antimicrobial therapy aimed at achieving synergistic bactericidal activity against *Klebsiella pneumoniae* central nervous system infections, which are frequently multidrug-resistant or healthcare-associated Synergy is sought in this setting to enhance central nervous s...

Instead, it describes a therapeutic strategy involving combination antimicrobial therapy aimed at achieving synergistic bactericidal activity against *Klebsiella pneumoniae* central nervous system infections, which are frequently multidrug-resistant or healthcare-associated *Klebsiella* meningitis is a severe, life-threatening infection of the leptomeninges and subarachnoid space that most commonly affects neonates, immunocompromised hosts, and patients following neurosurgical procedures or head...

*Klebsiella* meningitis is a severe, life-threatening infection of the leptomeninges and subarachnoid space that most commonly affects neonates, immunocompromised hosts, and patients following neurosurgical procedures or head trauma

It is characterized pathologically by intense purulent meningeal inflammation and clinically by rapid-onset fever, headache, meningismus, altered consciousness, and elevated intracranial pressure Synergy is sought in this setting to enhance central nervous system drug penetration, overcome high-level beta-lactamase or carbapenem resistance, and accelerate cerebrospinal fluid sterilization to reduce high rates of mortality and permanent neurological sequelae

It is characterized pathologically by intense purulent meningeal inflammation and clinically by rapid-onset fever, headache, meningismus, altered consciousness, and elevated intracranial pressure